News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>Citi Expects Great Chance of US Fentanyl Tariff Cut, CN Stimulus Policy Launch Less Urgent
The US-China tariff reduction exceeded the upper end of its expectations, Citi Research issued a research report saying. According to estimations, the effective US tariff on China ...
Reset
Send
The window will close in 5 seconds
<Research>Citi Expects Great Chance of US Fentanyl Tariff Cut, CN Stimulus Policy Launch Less Urgent
Close
Recommend
4
Positive
8
Negative
3
 
 

The US-China tariff reduction exceeded the upper end of its expectations, Citi Research issued a research report saying.

According to estimations, the effective US tariff on China has fallen to 38.6%, returning to a non-restrictive period. Looking ahead, the broker believed that the 20% tariff on fentanyl is also likely to be reduced. If the US tariff on fentanyl is withdrawn, this will further remove the external barrier to the Chinese economy.

Related NewsM Stanley: US-CN Trade Talks Achieve Substantial Progress, Positive Catalyst for CN Mkt in Near Term
When the trade tensions slow down, the urgency for the authorities to launch stimulus policies, especially fiscal policies, is significantly reduced, the report added.

Citi Research had earlier expected China to launch RMB1.5 trillion of fiscal/ quasi-fiscal incremental funds by the middle of 2025 to offset the impact of the US tariffs. However, with the US tariffs back to a non-restrictive period, the likelihood drops significantly.

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.